DOP2002000461A - DERIVATIVES OF SULFONAMIDE. - Google Patents
DERIVATIVES OF SULFONAMIDE.Info
- Publication number
- DOP2002000461A DOP2002000461A DO2002000461A DO2002000461A DOP2002000461A DO P2002000461 A DOP2002000461 A DO P2002000461A DO 2002000461 A DO2002000461 A DO 2002000461A DO 2002000461 A DO2002000461 A DO 2002000461A DO P2002000461 A DOP2002000461 A DO P2002000461A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- sulfonamide
- treatment
- derivatives
- present
- ccr3
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title abstract 2
- 150000003456 sulfonamides Chemical class 0.000 title abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- NDZYPHLNJZSQJY-QNWVGRARSA-N 1-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-3-[(1r,2s)-2-[[(3s)-3-[(4-fluorophenyl)methyl]piperidin-1-yl]methyl]cyclohexyl]urea Chemical compound CC1=C(C(=O)C)SC(NC(=O)N[C@H]2[C@@H](CCCC2)CN2C[C@H](CC=3C=CC(F)=CC=3)CCC2)=N1 NDZYPHLNJZSQJY-QNWVGRARSA-N 0.000 abstract 1
- HFFXLYHRNRKAPM-UHFFFAOYSA-N 2,4,5-trichloro-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(Cl)C=2)Cl)=N1 HFFXLYHRNRKAPM-UHFFFAOYSA-N 0.000 abstract 1
- 206010003645 Atopy Diseases 0.000 abstract 1
- 102100024167 C-C chemokine receptor type 3 Human genes 0.000 abstract 1
- 101710149862 C-C chemokine receptor type 3 Proteins 0.000 abstract 1
- 102000009410 Chemokine receptor Human genes 0.000 abstract 1
- 108050000299 Chemokine receptor Proteins 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 206010039085 Rhinitis allergic Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010105 allergic rhinitis Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un derivado de sulfonamida que es útil como ingrediente activo de preparaciones farmacéuticas. Los derivados de sulfonamida de la presente invención tienen actividad antagonista de CCR3 (receptor de quimioquinas de tipo CC), y pueden usarse para la profilaxis y tratamiento de enfermedades asociadas con la actividad de CCR3, en particular, para el tratamiento del asma, la dermatitis atópica, la rinitis alérgica y otros trastornos inflamatorios/inmunológicos.The present invention relates to a sulfonamide derivative that is useful as an active ingredient in pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 antagonist activity (CC type chemokine receptor), and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular, for the treatment of asthma, dermatitis. atopic, allergic rhinitis and other inflammatory / immune disorders.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2002000461A DOP2002000461A (en) | 2002-09-04 | 2002-09-04 | DERIVATIVES OF SULFONAMIDE. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DO2002000461A DOP2002000461A (en) | 2002-09-04 | 2002-09-04 | DERIVATIVES OF SULFONAMIDE. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2002000461A true DOP2002000461A (en) | 2003-03-15 |
Family
ID=44261096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2002000461A DOP2002000461A (en) | 2002-09-04 | 2002-09-04 | DERIVATIVES OF SULFONAMIDE. |
Country Status (1)
| Country | Link |
|---|---|
| DO (1) | DOP2002000461A (en) |
-
2002
- 2002-09-04 DO DO2002000461A patent/DOP2002000461A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28239A1 (en) | BENCENOSULFONAMIDE DERIVATIVES | |
| MY133303A (en) | Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders | |
| GT200400079A (en) | PIRIMIDINE DERIVATIVES | |
| BR112018073663A2 (en) | Spiro-lactam nmda receptor modulators and their uses | |
| MX2020003415A (en) | BENZOXACEPINE OXAZOLIDINONE COMPOUNDS AND METHODS OF USE. | |
| CL2020000747A1 (en) | Niraparib formulations. | |
| CL2011000306A1 (en) | Compounds derived from di-alkylamide of 7-cyclopentyl-2- [5- (piperidin or substituted piperazin) -pyridin-2-yl amino] -7h-pyrrolo- [2,3-d] -pyrimidin-6-carboxylic acid, cdk4 inhibitors; pharmaceutical composition; and its use for the treatment of cancer or inflammation. | |
| BR112015021888A8 (en) | dna-pk inhibitors, their uses and pharmaceutical composition | |
| DOP2013000105A (en) | DERIVATIVES OF 2,3-DIHYDROIMIDAZO [1,2-C] QUINAZOLINA SUBSTITUTED WITH AMINOALCOHOLES THAT ARE USEFUL TO TREAT HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
| BR112018015273A2 (en) | benzimidazole derivatives as ror-gamma modulators | |
| BR112014029310A2 (en) | heterocyclic pyrimidine analogs as tyk2 inhibitors | |
| DK2321321T3 (en) | TRIAZOLO [4,5-D] PYRAMIDE INGREDIENTS AND USE THEREOF AS PURINE RECEPTOR ANTAGONISTS | |
| CO2019000938A2 (en) | Nmda spiro-lactam modulators and methods of use thereof | |
| CO2019000941A2 (en) | Modulators of the nmda spiro-lactam receptor and use thereof | |
| CO2019000944A2 (en) | Modulators of the nmda spiro-lactam and bis-spiro-lactam receptor and use thereof | |
| UY32833A (en) | DP2 ANTAGONISTS AND USES OF THE SAME | |
| BR112021009078A8 (en) | SUBSTITUTED ADENOSINE RECEPTOR ANTAGONISTS OF AMINOTRIAZOLOPYRIMIDINE AND AMINOTRIAZOLOPYRAZINE, PHARMACEUTICAL COMPOSITIONS AND THEIR USES | |
| MX2021006012A (en) | 7-, 8-, and 10-SUBSTITUTED AMINO TRIAZOLO QUINAZOLINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS AND THEIR USE. | |
| PA8566501A1 (en) | NICOTINAMIDE DERIVATIVES AND A COMBINATION TIOTROPIO SALT FOR THE TREATMENT OF DISEASES | |
| AR114032A2 (en) | 5- (3,4-DICHLORO-PHENYL) -N- (2-HYDROXY-CYCLOHEXYL) -6- (2,2,2-TRIFLUOR-ETOXY) -NICOTINAMIDE AND SALTS THEREOF | |
| PE20250018A1 (en) | PHARMACEUTICAL DOSAGE FORMS COMPRISING (4S)-24-CHLORINE-4-ETHYL-73-FLUORO-35- METHOXY-32,5-DIOXO-14-(TRIFLUOROMETHYL)-32H-6-AZA-3(4,1)-PYRIDINE-1(1)-[1,2,3]TRIAZOLE- 2(1,2),7(1)-DIBENZENEHEPTAPHANO-74-CARBOXAMIDE | |
| CL2010001566A1 (en) | Compound derived from piperidinyl, modulator of the activity of chemokine receptors; pharmaceutical composition that includes them; and its use in the treatment of inflammatory, allergic, autoimmune diseases. | |
| DOP2002000461A (en) | DERIVATIVES OF SULFONAMIDE. | |
| UY27430A1 (en) | DERIVATIVES OF SULFONAMIDE. | |
| CO2024002715A2 (en) | Radiprodil formulations |